By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than 8 million deaths around the world every year.
The rise of AI and data centers is creating a large demand for energy, and many firms on Wall Street believe this company can ...
Everything you need to know about how we analyzed the 13,000+ comments submitted in the federal government’s request for ...
A campaign active since last November has been targeting Python developers building Telegram bots with trojanized Pyrogram ...
New benchmarks show semantic code graphs helping coding agents find change locations faster and complete updates more ...
How-To Geek on MSN
I stopped maintaining 30 JSON files by hand with this one tool
Connect all your configuration files and autogenerate code—Jsonnet is the missing piece for large code bases.
Comedy is subjective, but some movies have managed to make generations of viewers laugh for decades, from the slapstick stuff ...
How-To Geek on MSN
Claude Code isn't good at everything, but it's amazing at these 5 tasks
Claude cannot think; it can only imitate. You must treat it like a fancy autocomplete and not like a programmer.
Discover the top 12 tools in 2026, from Cursor to Copilot, to speed up daily dev workflows and build apps faster!
Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results